Skip to content
10-Q

Quarterly Report

INSMED INCORPORATED INSM

0001104506-25-000026

← back to feed
Filed
May 8, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · May 2, 2025 182.14M sh
Long Term Debt Q1 2025 · Mar 31, 2025 $1.11B
Long Term Debt Q1 2025 · Dec 31, 2024 $1.1B
Cash And Equivalents Q1 2025 · Mar 31, 2025 $403.25M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $555.03M
Current Liabilities Q1 2025 · Mar 31, 2025 $239.23M
Current Liabilities Q1 2025 · Dec 31, 2024 $297.53M
Total Liabilities Q1 2025 · Mar 31, 2025 $1.7B
Total Liabilities Q1 2025 · Dec 31, 2024 $1.74B
Current Assets Q1 2025 · Mar 31, 2025 $1.4B
Current Assets Q1 2025 · Dec 31, 2024 $1.62B
Total Assets Q1 2025 · Mar 31, 2025 $1.8B
Total Assets Q1 2025 · Dec 31, 2024 $2.03B
Shares Diluted Q1 2025 · Mar 31, 2024 148.46M sh
Capex Q1 2025 · Mar 31, 2024 $4.68M
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$184.04M
Stockholders Equity Q1 2025 · Mar 31, 2024 −$464.81M
Stockholders Equity Q1 2025 · Dec 31, 2023 −$331.92M
Eps Diluted Q1 2025 · Mar 31, 2024 −$1.06
Eps Basic Q1 2025 · Mar 31, 2024 −$1.06
Sga Expense Q1 2025 · Mar 31, 2024 $93.1M
Rd Expense Q1 2025 · Mar 31, 2024 $121.08M
Net Income Q1 2025 · Mar 31, 2024 −$157.09M
Operating Income Q1 2025 · Mar 31, 2024 −$145.51M
Cost Of Revenue Q1 2025 · Mar 31, 2024 $17.46M
Revenue Q1 2025 · Mar 31, 2024 $75.5M